Ischemic change in gastric mucosa due to gastric wall expansion with air supply: Real-time capture in upper gastrointestinal endoscopy

Digestive Endoscopy　/　2022

Characterization of innate immune response to hepatitis B virus genotype F acute infection in tree shrew (Tupaia belangeri) model

Front. Virol　/　2022

Mac-2 Binding Protein Glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa

J Glob Health　/　2022

Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy

J Hepatol　77,P.967-977　/　2022

Ischemic change in gastric mucosa due to gastric wall expansion with air supply: Real-time capture in upper gastrointestinal endoscopy

Digestive Endoscopy　/　2022

Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy

J Hepatol　/　2022

Rapid point-of-care test for hepatitis B core-related antigen to diagnose high viral load in resource-limited settings

Clin Gastroenterol Hepatol　/　2022

Clinical usefulness of a novel high-sensitivity hepatitis B core-related antigen assay to determine the initiation of treatment for HBV reactivation

J　Gastroenterol　/　2022

Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels.

J Hepatol.　S0168-8278(22)00020-4.　/　2022

Management of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection based on a highly sensitive HB core-related antigen assay.

Hepatol Res　/　2022

Blocking neddylation elicits antiviral effect against hepatitis B virus replication.

Mol Biol Rep　49,P.403-412　/　2022

Bile acid dysmetabolism in the gut-microbiota-liver axis under hepatitis C virus infection.

Liver Int.　42,P.124-134　/　2022

Time-course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis.

Hepatol Res　52,P.235-246　/　2022

Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019.

Sci Rep.　12,P.1517　/　2022

Mac-2-Binding Protein Glycan Isomer Predicts All Malignancies Post-sustained Virological Response in Chronic Hepatitis C

Hepatol Commun　/　2022

Endoscopic direct clipping versus indirect clipping for colonic diverticular bleeding: A large multicenter cohort study

United European Gastroenterol J　10,P.93-103　/　2022

Optimal management of lenvatinib therapy for patients with unresectable hepatocellular carcinoma by balancing the therapeutic effect with the relative dose intensity

Hepatol Res　52,P.105-119　/　2022

Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine.

Clin Gastroenterol Hepatol　20,P.874-885.e4　/　2022

Identification of microRNA‐96‐5p as a postoperative, prognostic microRNA predictor in nonviral hepatocellular carcinoma.

Hepatol Res　52,P.93-104　/　2022

B型肝炎の最新治療-創薬研究から臨床応用へ-

日本消化器病学会雑誌　119,P.802-811　/　2022

内視鏡的に2年間の経過観察で発見した進行胃癌の1例

医学書院　胃と腸　57,P.1203-1206　/　2022

"特集　B型肝炎ウイルスに対する飽くなき挑戦 「HBV RNA阻害薬」"

週刊　医学のあゆみ/医歯薬出版株式会社　Vol.281,P.257-260　/　2022

"特集　B型肝炎ウイルスに対する飽くなき挑戦 「高感度HBコア関連抗原測定法「iTACT-HBcrAG）の臨床応用」"

週刊　医学のあゆみ/医歯薬出版株式会社　Vol.281,P.238-242　/　2022

"特集　B型肝炎ウイルスに対する飽くなき挑戦 「はじめに」"

週刊　医学のあゆみ/医歯薬出版株式会社　Vol.281,P.227-228　/　2022

熊本脂肪肝プロジェクト

人吉医療センター　広報誌　翔　4月　/　2022

My　Favorite Papers

週刊医学界新聞/医学書院　5月23日,P.3　/　2022

愛知県の職域肝炎ウイルス検査促進事業の成果～全国健康保険協会愛知支部の取り組み～

日本臨床検査医学会誌　3月10日,P.295-300　/　2022

C型肝炎　抗原検査で検出

熊本日日新聞　4/8掲載,P.4　/　2022

B型肝炎

週刊日本医事新報　3月1週号,P.36-37　/　2022

HCV（C型肝炎ウイルス）抗原検査を受けましょう！

熊本日日新聞　3/21掲載　/　2022

ステロイドを含む免疫抑制剤によるHBV再活性化の現状と対策～高感度抗原検査の有用性

あらお医報/荒尾医師会　3/5発行,P.14-15　/　2022

熊本肝炎・脂肪肝早期発見・治療サポートプロジェクト

熊本日日新聞　3/7掲載　/　2022